Last updated: March 20, 2023
Sponsor: Chulalongkorn University
Overall Status: Completed
Phase
N/A
Condition
Common Cold
Allergy (Pediatric)
Acute Rhinitis
Treatment
N/AClinical Study ID
NCT05779046
EX PHYSIO SPSC 5
Ages 18-35 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects had a clinical history of persistent rhinitis, and had positive skin pricktest to house dust mite (D. pteronyssinus)
- Persistent allergic rhinitis
- Subjects with known asthma, chronic rhinosinusitis, Lung cancer and Emphysema diseaseswere excluded.
- BMI 18.5 - 24.9 kg/m2
- Subjects will ask to abstain from taking antihistamine for at least 5 days,leukotriene receptor antagonist for at least 1 week, and nasal steroids for at least 2weeks prior to the start of the experiment.
- Subjects will ask to abstain from taking any form of dietary supplement during theexperiment.
- Subjects had no exercise training program (not exercise regularly or not exercise for 30 minutes or more at least 3 times per week during the past 6 months)
Exclusion
Exclusion Criteria:
- Accident that are unable to continue the research, such as accidental injury orillness, etc.
- Participants did not voluntarily participate.
Study Design
Total Participants: 12
Study Start date:
September 10, 2022
Estimated Completion Date:
December 20, 2022
Study Description
Connect with a study center
Faculty of Sports Science, Chulalongkorn University
Pathum Wan, Bangkok 10330
ThailandSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.